Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p-Reference-Cited by-同舟云学术

Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p

Published:2021-08-26 Issue:6 Volume:43 Page:680-692
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Fu Tingkai¹,Yang Yunxue¹,Mu Zhenxin¹,Sun Rongwei¹,Li Xingang²,Dong Jun¹

Affiliation:

1. Department of Neurosurgery, People’s Hospital of Rizhao, Rizhao City, China

2. Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2021.1966031

Reference60 articles.

1. Molecular targeted therapy of glioblastoma

2. Circulating biomarkers in patients with glioblastoma

3. A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis

4. Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas

5. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC01410 accelerates the invasion of trophoblast cells by modulating METTL3/Fas;Molecular Biology Reports;2024-08-08

2. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance;Biochemical Pharmacology;2024-08

3. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide;Molecular Neurobiology;2024-07-18

4. Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma;Non-coding RNA Research;2024-06

5. A comprehensive review of molecular optimization in artificial intelligence‐based drug discovery;Quantitative Biology;2024-02-12